XIAP, as the strongest anti-apoptotic factor in the inhibitors of apoptosis family, is expressed at a significantly higher level in patients with CML than in normal subjects (Zhao and Ma, 2013). This evidence concerns the gene XIAP and chronic myelogenous leukemia, BCR-ABL1 positive.